Literature DB >> 1847282

Mineral balance in infantile cortical hyperostosis: effects of corticosteroids.

D G Barr1, N R Belton.   

Abstract

The effects on mineral metabolism of therapeutic doses of corticosteroids were investigated in infantile cortical hyperostosis; in four untreated cases the calcium, phosphorus, and magnesium balances were strongly positive. In one severe case, treatment with prednisolone was associated with an alteration to negative calcium and magnesium balance, and faecal losses of calcium were particularly high. This effect persisted for at least three months after the steroids had been discontinued, and during this period there was pronounced retardation of linear growth. Six months after the treatment had been stopped mineral balance was again positive and there was rapid 'catch up' in growth. In infancy, the negative effect of corticosteroids on calcium, phosphorus, and magnesium metabolism may contribute to inhibition of bone growth and steroid stunting.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847282      PMCID: PMC1793178          DOI: 10.1136/adc.66.1.140

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Aminoaciduria in a case of infantile cortical hyperostosis.

Authors:  D J CAMPBELL; E J TURNER
Journal:  Am J Clin Pathol       Date:  1962-10       Impact factor: 2.493

2.  STUDIES IN RHEUMATIC FEVER. IV. ATTEMPTS TO OFFSET THE CALCIUM LOSSES INCIDENTAL TO STEROID THERAPY.

Authors:  G MANSON; J A JOHNSTON
Journal:  Am J Dis Child       Date:  1965-06

3.  Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus.

Authors:  S O'Regan; R W Chesney; A Hamstra; J A Eisman; A M O'Gorman; H F Deluca
Journal:  Acta Paediatr Scand       Date:  1979-01

Review 4.  Corticosteroids and growth.

Authors:  J S Hyams; D E Carey
Journal:  J Pediatr       Date:  1988-08       Impact factor: 4.406

5.  Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy.

Authors:  Y Suzuki; Y Ichikawa; E Saito; M Homma
Journal:  Metabolism       Date:  1983-02       Impact factor: 8.694

6.  Catch-up growth in cortisone-treated rats: effects of calcium and vitamin D.

Authors:  I Mitchell; D G Barr; S J Pocock
Journal:  Pediatr Res       Date:  1978-12       Impact factor: 3.756

7.  Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids.

Authors:  P D Saville; O Kharmosh
Journal:  Arthritis Rheum       Date:  1967-10

8.  Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.

Authors:  R W Chesney; R B Mazess; A J Hamstra; H F DeLuca; S O'Reagan
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

9.  Effect of prednisone on growth and bone mineral content in childhood glomerular disease.

Authors:  R W Chesney; R B Mazess; P Rose; D K Jax
Journal:  Am J Dis Child       Date:  1978-08

10.  Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess.

Authors:  E Seeman; R Kumar; G G Hunder; M Scott; H Heath; B L Riggs
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more
  1 in total

1.  Infantile cortical hyperostosis: two cases with varied presentations.

Authors:  Pravakar Mishra; Shasanka Shekhar Panda; Manoranjan Tripathy; Meely Panda; Rashmi Ranjan Das
Journal:  J Clin Diagn Res       Date:  2014-10-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.